Mr Andrew Levander > Dechert LLP > New York, United States > Lawyer Profile

With the ability to ‘translate complex legal analysis into practical and actionable advise’, Dechert LLP is a highly reputed outfit for both individual and corporate representation in the white-collar space. Supplementing its domestic expertise with strong offices in major international hubs, the practice is well-equipped to handle cross-border investigations and litigation opposite global regulatory authorities. Former US Attorney David Kelley and trial lawyer David Kistenbroker jointly lead the practice out of New York, where Andrew Levander and Jonathan Streeter are further names to note. Washington DC’s Catherine Botticelli, who regularly advises clients stemming from the financial services sector, provides ‘deep investigative skills and a focused, constructive approach in dealing with regulators‘. On the West Coast, San Francisco-based Hartley West has extensive experience dealing with allegations of fraud, corruption, and money laundering.

The trial, investigations and securities practice at Dechert LLP has a deep bench of partners who represent a diverse range of clients, among them leading mutual funds and corporate issuers of securities. Practice head David Kistenbroker and key partner Joni Jacobsen, who work out of both the Chicago and New York offices, are highly praised by peers. They are currently handling a class action against Antares Pharma, Inc. that alleges the company provided insufficient information to the FDA in support of testosterone replacement therapy Xyosted and subsequently overstated the drug’s approval prospects, rendering public statements false and misleading. Regulatory enforcement specialist Michael Doluisio in Philadelphia and New York litigation partner Andrew Levander are acting for AmerisourceBergen Corp. in a shareholder derivative suit filed in Delaware Chancery Court accusing the company breaching its fiduciary duties by failing to oversee compliance with federal regulations concerning distribution of controlled substances and their contributing to the opioid epidemic. Matthew Larrabee, Andrew Levander and Linda Goldstein are the key practitioners in New York. In San Francisco, corporate governance litigation partner Richard Horvath and securities and antitrust partner Josh Hess are the main contacts.

The trial, investigations and securities practice at Dechert LLP has a deep bench of partners who represent a diverse range of clients, among them leading mutual funds and corporate issuers of securities. Practice head David Kistenbroker and key partner Joni Jacobsen, who work out of both the Chicago and New York offices, are highly praised by peers. They are currently handling a class action against Antares Pharma, Inc. that alleges the company provided insufficient information to the FDA in support of testosterone replacement therapy Xyosted and subsequently overstated the drug’s approval prospects, rendering public statements false and misleading. Regulatory enforcement specialist Michael Doluisio in Philadelphia and New York litigation partner Andrew Levander are acting for AmerisourceBergen Corp. in a shareholder derivative suit filed in Delaware Chancery Court accusing the company breaching its fiduciary duties by failing to oversee compliance with federal regulations concerning distribution of controlled substances and their contributing to the opioid epidemic. Matthew Larrabee, Andrew Levander and Linda Goldstein are the key practitioners in New York. In San Francisco, corporate governance litigation partner Richard Horvath and securities and antitrust partner Josh Hess are the main contacts.

Acting for corporates, sovereign states, financial institutions and creditors, Dechert LLP has broad international litigation experience including acting in parallel proceedings across multiple jurisdictions as well as distressed financial situations, investigations and judgement enforcement. Catherine Botticelli and Jonathan Streeter, based in Washington DC and New York respectively, lead the practice. Meanwhile, Andrew Levander and Mauricio España, based in New York, focus on commercial litigation, white-collar and regulatory investigations. Also in New York is Linda Goldstein who concentrates on securities litigation including claims brought by institutional investors and class actions, and co-head of the firm’s insolvency litigation group, Gary Mennitt, is experienced in multinational contentious matters particularly relating to creditors’ rights and bondholders.